Literature DB >> 9067063

Epidemiology of schizophrenia.

H Häfner1, W an der Heiden.   

Abstract

OBJECTIVE: To characterize the epidemiology of schizophrenia.
METHOD: Narrative literature review.
RESULTS: Each year 1 in 10,000 adults (12 to 60 years of age) develops schizophrenia. Based on a restrictive and precise definition of the diagnosis and using standardized assessment methods and large, representative populations, the incidence rates appear stable across countries and cultures and over time, at least for the last 50 years. Schizophrenic patients are not born into ecological and social disadvantage. The uneven distribution of prevalence rates is a result of social selection: an early onset leads to social stagnation, a late onset to descent from a higher social status. The main age range of risk for schizophrenia is 20 to 35 years. It is still unclear whether schizophrenia-like late-onset psychoses (for example, late paraphrenia) after age 60 should be classified as schizophrenia either psychopathologically or etiologically. In 75% of cases, first admission is preceded by a prodromal phase with a mean length of 5 years and a psychotic prephase of one year's duration. On average, women fall ill 3 to 4 years later than men and show a second peak of onset around menopause. Consequently, late-onset schizophrenias are more frequent and more severe in women than in men. The sex difference in age of onset is smaller in cases with a high genetic load and greater in cases with a low genetic load. Type of onset and core symptoms do not differ between the sexes. The most pronounced sex difference is the socially negative illness behaviour of young men.
CONCLUSIONS: Among the factors determining social course and outcome are level of social development at onset, the disorder itself (for example, genetic liability, severity of symptoms, and functional deficits), general biological factors (for example, estrogen), and sex- and age-specific illness behaviour.

Entities:  

Mesh:

Year:  1997        PMID: 9067063     DOI: 10.1177/070674379704200204

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  41 in total

1.  Transgenic mice overexpressing the extracellular domain of NCAM are impaired in working memory and cortical plasticity.

Authors:  Leann H Brennaman; Gaga Kochlamazashvili; Luminita Stoenica; Randall J Nonneman; Sheryl S Moy; Melitta Schachner; Alexander Dityatev; Patricia F Maness
Journal:  Neurobiol Dis       Date:  2011-04-16       Impact factor: 5.996

2.  Costs of new atypical antipsychotic agents for schizophrenia: does unrestricted access reduce hospital utilization?

Authors:  Daria O'Reilly; David Craig; Leslie Phillips; Ron Goeree; Jean-Eric Tarride; Patrick Parfrey
Journal:  Healthc Policy       Date:  2007-08

Review 3.  Clinical usefulness of second-generation antipsychotics in treating children and adolescents diagnosed with bipolar or schizophrenic disorders.

Authors:  Salvatore Gentile
Journal:  Paediatr Drugs       Date:  2011-10-01       Impact factor: 3.022

4.  A survey of psychosis risk symptoms in Kenya.

Authors:  Daniel Mamah; Anne Mbwayo; Victoria Mutiso; Deanna M Barch; John N Constantino; Thelma Nsofor; Lincoln Khasakhala; David M Ndetei
Journal:  Compr Psychiatry       Date:  2011-09-25       Impact factor: 3.735

5.  Ziprasidone and the pharmacokinetics of a combined oral contraceptive.

Authors:  G J Muirhead; J Harness; P R Holt; S Oliver; R J Anziano
Journal:  Br J Clin Pharmacol       Date:  2000       Impact factor: 4.335

Review 6.  Role of estrogen treatment in the management of schizophrenia.

Authors:  Jayashri Kulkarni; Emmy Gavrilidis; Roisin Worsley; Emily Hayes
Journal:  CNS Drugs       Date:  2012-07-01       Impact factor: 5.749

Review 7.  22q11 deletion syndrome: a genetic subtype of schizophrenia.

Authors:  A S Bassett; E W Chow
Journal:  Biol Psychiatry       Date:  1999-10-01       Impact factor: 13.382

8.  Neuropsychological profiles in different at-risk states of psychosis: executive control impairment in the early--and additional memory dysfunction in the late--prodromal state.

Authors:  Ingo Frommann; Ralf Pukrop; Jürgen Brinkmeyer; Andreas Bechdolf; Stephan Ruhrmann; Julia Berning; Petra Decker; Michael Riedel; Hans-Jürgen Möller; Wolfgang Wölwer; Wolfgang Gaebel; Joachim Klosterkötter; Wolfgang Maier; Michael Wagner
Journal:  Schizophr Bull       Date:  2010-01-06       Impact factor: 9.306

9.  Prenatal and perinatal risk factors for schizophrenia, affective psychosis, and reactive psychosis of early onset: case-control study.

Authors:  C M Hultman; P Sparén; N Takei; R M Murray; S Cnattingius
Journal:  BMJ       Date:  1999-02-13

10.  Subjective burden on spouses of schizophrenia patients.

Authors:  Surekha Kumari; A R Singh; A N Verma; P K Verma; S Chaudhury
Journal:  Ind Psychiatry J       Date:  2009-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.